{"title":"肝棘球蚴病化脓性并发症预后和预防的免疫学特征","authors":"Khamdamov Bakhtiyor Zarifovich, Safarov Sunnat Sattorovich, Abdurakhmanov Mamur Mustafayevich, Khamdamov Alisherjon Bakhtiyorovich","doi":"10.37547/tajmspr/volume06issue02-13","DOIUrl":null,"url":null,"abstract":"The application of the developed therapeutic and diagnostic algorithms allowed, in the main group of patients in comparison with the control group, to increase the number of good treatment results from 30.9% to 35.1%, satisfactory - from 53.4% to 56.4% and to reduce unsatisfactory treatment results from 14.8% to 8.1%, and lethality - from 1.0% to 0.3%.","PeriodicalId":494509,"journal":{"name":"The American journal of medical sciences and pharmaceutical research","volume":"43 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IMMUNOLOGIC CHARACTERIZATION OF PECULIARITIES OF PROGNOSIS AND PROPHYLAXIS OF PURULENT-SEPTIC COMPLICATIONS OF LIVER ECHINOCOCCOSIS\",\"authors\":\"Khamdamov Bakhtiyor Zarifovich, Safarov Sunnat Sattorovich, Abdurakhmanov Mamur Mustafayevich, Khamdamov Alisherjon Bakhtiyorovich\",\"doi\":\"10.37547/tajmspr/volume06issue02-13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The application of the developed therapeutic and diagnostic algorithms allowed, in the main group of patients in comparison with the control group, to increase the number of good treatment results from 30.9% to 35.1%, satisfactory - from 53.4% to 56.4% and to reduce unsatisfactory treatment results from 14.8% to 8.1%, and lethality - from 1.0% to 0.3%.\",\"PeriodicalId\":494509,\"journal\":{\"name\":\"The American journal of medical sciences and pharmaceutical research\",\"volume\":\"43 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The American journal of medical sciences and pharmaceutical research\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.37547/tajmspr/volume06issue02-13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of medical sciences and pharmaceutical research","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.37547/tajmspr/volume06issue02-13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IMMUNOLOGIC CHARACTERIZATION OF PECULIARITIES OF PROGNOSIS AND PROPHYLAXIS OF PURULENT-SEPTIC COMPLICATIONS OF LIVER ECHINOCOCCOSIS
The application of the developed therapeutic and diagnostic algorithms allowed, in the main group of patients in comparison with the control group, to increase the number of good treatment results from 30.9% to 35.1%, satisfactory - from 53.4% to 56.4% and to reduce unsatisfactory treatment results from 14.8% to 8.1%, and lethality - from 1.0% to 0.3%.